S Miwa, T Nojima, A A Alomesen, H Ikeda, N Yamamoto, H Nishida, K Hayashi, A Takeuchi, K Igarashi, T Higuchi, et al. Associations of PD-L1, PD-L2, and HLA class I expression with responses to immunotherapy in patients with advanced sarcoma: post hoc analysis of a phase 1/2 trial. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2021. 23. 8. 1620-1629
Gang Xu, Hisaki Aiba, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Takashi Higuchi, Kensaku Abe, Yuta Taniguchi, Yoshihiro Araki, et al. Efficacy of perioperative chemotherapy for synovial sarcoma: a retrospective analysis of a Nationwide database in Japan. BMC cancer. 2021. 21. 1. 773-773
HIROMICHI OSHIRO, YASUNORI TOME, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, FUMINORI KANAYA, KOTARO NISHIDA, ROBERT M. HOFFMAN. Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease. Anticancer Research. 2021. 41. 7. 3287-3292
Norihiko Sugisawa, Takashi Higuchi, Qinghong Han, Chihiro Hozumi, Jun Yamamoto, Yoshihiko Tashiro, Hiroto Nishino, Kei Kawaguchi, Michael Bouvet, Takuya Murata, et al. Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Cancer chemotherapy and pharmacology. 2021. 88. 1. 61-67
Pioglitazone, an Agonist of Peroxisome Proliferator-Activated Receptor Gamma, Overcomes Doxorubicin-Resistance in an Osteosarcoma Patient-Derived Orthotopic Xenograft Nude Mouse Model by Modulating P-Glycoprotein
(2021 Annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) 2021)
Efficacy of olaratumab in combination with different standard chemotherapeutic regimens in soft tissue sarcoma treatment: in vivo study using patient-derived orthotopic xenograft (PDOX) mouse model
(13th Asia Pacific Musculoskeletal Tumor Society Meeting)
Activation and induction of PPARγ using a non-steroidal inflammatory drug inhibits cell progression in chondrosarcoma cells
(13th Asia Pacific Musculoskeletal Tumor Society Meeting)